Skip to content

On this page

Loqtorzi

toripalimab-tpzi

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Loqtorzi

Proper name

toripalimab-tpzi

Licence type

351(a)

BLA number

761240

Applicant

Coherus BioSciences, Inc.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
240MG/6ML (40MG/ML)	Injection	Intravenous	Single-Dose Vial	Rx	October 27, 2023

Exclusivity

Source: Purple Book

Kind	Expires
Orphan exclusivity	October 27, 2030

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity